000 03035cam a2200349 a 4500
003 EG-GiCUC
005 20250223032757.0
008 210801s2021 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aM.Sc
099 _aCai01.11.07.M.Sc.2021.Su.R
100 0 _aSusan Sameh Ahmed Fathy Elzayat
245 1 0 _aRole of ESR1 and FTO genetic variants on weight loss and glycemic control in obese patients undergoing bariatric surgery /
_cSusan Sameh Ahmed Fathy Elzayat ; Supervised Marwa Mohamed Sheta , Mohamed Diaa Eldin Sarhan , Tarek Abdelazim Ramzy
246 1 5 _aفى فقدان الوزن و مراقبه نسبه السكر فى الدم فى المرضى الذين يعانون من السمنة المفرطة وسيخضعون لجراحه لعلاج البدانة FTO و ESR1 دور المتغيرات الوراثية
260 _aCairo :
_bSusan Sameh Ahmed Fathy Elzayat ,
_c2021
300 _a127 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology
520 _aBackground: Significant variability in weight loss and glycemic control has been observed in obese patients undergoing bariatric surgery. Genetic factors may play a role in the different outcomes. Objectives: The aim of this study is to detect the effect of genetic variants within the FTO gene (rs9939609) and ESR1 gene (rs712221) on weight loss and glycemic control in obese patients 6 months after laparoscopic sleeve gastrectomy. Patients and Methods: Ninety obese patients with BMI {u2265} 35 kg/m2undergoing laparoscopic sleeve gastrectomywere recruited and followed up after 6 months. All were subjected to history taking, clinical examination, routine laboratory investigations and genotyping for FTO gene (rs9939609) and ESR1 gene (rs712221) usingReal Time-PCR (TaqMan probes). Results: FTO (rs9939609) risk genotype AA is found to be associated with more obesity before operation (P-value 0.005) and lead to successful surgery and weight loss (P-value 0.023, OR 0.080, 95%CI 0.009-0.702). Patients with risk allele A had more weight loss and BMI loss after operation compared to patients with non-risk allele T (P-value <0.001). ESR1 (rs712221) risk genotype TT is found to be associated with more weight loss 6 months after surgery when compared to non-risk genotypes TA and AA (P-value 0.001). Patients with risk allele T had more weight loss, BMI loss and HbA1c loss after operation compared to patients with non-risk allele A (P-value <0.001)
530 _aIssued also as CD
653 4 _aESR1
653 4 _aFTO
653 4 _alaparoscopic sleeve gastrectomy
700 0 _aMarwa Mohamed Sheta ,
_eSupervisor
700 0 _aMohamed Diaa Eldin Sarhan ,
_eSupervisor
700 0 _aTarek Abdelazim Ramzy ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aNazla
_eRevisor
905 _aShimaa
_eCataloger
942 _2ddc
_cTH
999 _c81533
_d81533